Equities Analysts Offer Predictions for Lexicon Pharmaceuticals, Inc.’s FY2024 Earnings (NASDAQ:LXRX)

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – Equities researchers at HC Wainwright issued their FY2024 earnings per share estimates for Lexicon Pharmaceuticals in a research note issued to investors on Monday, June 17th. HC Wainwright analyst J. Pantginis anticipates that the biopharmaceutical company will post earnings per share of ($0.65) for the year. HC […]

Leave a Reply

Your email address will not be published.

Previous post Regal Rexnord Co. (NYSE:RRX) Receives $192.00 Average PT from Analysts
Next post Brokerages Set Trinity Capital Inc. (NASDAQ:TRIN) Price Target at $15.50